Nishikawa M - Search Results

1

Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation.

Sakai M, Nishikawa M, Thanaketpaisarn O, Yamashita F, Hashida M. Sakai M, et al. Among authors: nishikawa m. Gene Ther. 2005 Apr;12(7):607-16. doi: 10.1038/sj.gt.3302435. Gene Ther. 2005. PMID: 15616599

2

Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine).

Mahato RI, Takemura S, Akamatsu K, Nishikawa M, Takakura Y, Hashida M. Mahato RI, et al. Among authors: nishikawa m. Biochem Pharmacol. 1997 Mar 21;53(6):887-95. doi: 10.1016/s0006-2952(96)00880-5. Biochem Pharmacol. 1997. PMID: 9113108

3

Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery.

Hirabayashi H, Nishikawa M, Takakura Y, Hashida M. Hirabayashi H, et al. Among authors: nishikawa m. Pharm Res. 1996 Jun;13(6):880-4. doi: 10.1023/a:1016053128569. Pharm Res. 1996. PMID: 8792426

4

In vivo gene delivery to the liver using novel galactosylated cationic liposomes.

Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M. Kawakami S, et al. Among authors: nishikawa m. Pharm Res. 2000 Mar;17(3):306-13. doi: 10.1023/a:1007501122611. Pharm Res. 2000. PMID: 10801219

5

Cell-specific delivery of genes with glycosylated carriers.

Hashida M, Nishikawa M, Yamashita F, Takakura Y. Hashida M, et al. Among authors: nishikawa m. Adv Drug Deliv Rev. 2001 Nov 19;52(3):187-96. doi: 10.1016/s0169-409x(01)00209-5. Adv Drug Deliv Rev. 2001. PMID: 11718943 Review.

6

Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives.

Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, Hashida M. Yabe Y, et al. Among authors: nishikawa m. J Pharmacol Exp Ther. 2001 Sep;298(3):894-9. J Pharmacol Exp Ther. 2001. PMID: 11504782

7

Pharmacokinetics of anticancer drugs, plasmid DNA, and their delivery systems in tissue-isolated perfused tumors.

Nishikawa M, Hashida M. Nishikawa M, et al. Adv Drug Deliv Rev. 1999 Nov 10;40(1-2):19-37. doi: 10.1016/s0169-409x(99)00038-1. Adv Drug Deliv Rev. 1999. PMID: 10837778

8

Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes.

Kawakami S, Sato A, Nishikawa M, Yamashita F, Hashida M. Kawakami S, et al. Among authors: nishikawa m. Gene Ther. 2000 Feb;7(4):292-9. doi: 10.1038/sj.gt.3301089. Gene Ther. 2000. PMID: 10694809

9

Design of polymeric prodrugs of PGE1 for cell-specific hepatic targeting.

Hashida M, Akamatsu K, Nishikawa M, Yamashita F, Yoshikawa H, Takakura Y. Hashida M, et al. Among authors: nishikawa m. Pharmazie. 2000 Mar;55(3):202-5. Pharmazie. 2000. PMID: 10756541

10

Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells.

Opanasopit P, Nishikawa M, Yamashita F, Takakura Y, Hashida M. Opanasopit P, et al. Among authors: nishikawa m. J Drug Target. 2001;9(5):341-51. doi: 10.3109/10611860108998770. J Drug Target. 2001. PMID: 11770704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results